Castle Biosciences (CSTL) Deferred Taxes (2021 - 2026)
Castle Biosciences' (CSTL) quarterly Deferred Taxes came in at -$10000.0 in Q1 2026, up 98.7% year-on-year from -$5032.7 in Q1 2025, and up 98.9% quarter-over-quarter from -$907000.0 in Q4 2025.
Castle Biosciences (CSTL) Deferred Taxes (2021 - 2026) Analysis & Trends
Castle Biosciences has disclosed Deferred Taxes across 6 years of filings, most recently posting -$10000.0 for Q1 2026.
- Deferred Taxes for Q1 2026 came in at -$10000.0, up 98.7% year-over-year; the trailing twelve-month figure through Mar 2026 was -$5.5 million (down 966.56% YoY), and the FY2025 annual result was -$6.2 million, down 544.54% from the prior year.
- Deferred Taxes came in at -$10000.0 for Q1 2026 at Castle Biosciences, up from -$907000.0 in the prior quarter.
- In the past five years, Deferred Taxes ranged from a high of $5.2 million in Q3 2024 to a low of -$4.7 million in Q2 2025.
- The 5-year median for Deferred Taxes is -$236000.0 (2023), against an average of -$533615.4.
- Across the five-year window, Deferred Taxes soared 99.57% in 2022 and sank 877.54% in 2024, its largest moves.
- Castle Biosciences' Deferred Taxes stood at -$38000.0 in 2022, then tumbled by 521.05% to -$236000.0 in 2023, then tumbled by 877.54% to -$2.3 million in 2024, then soared by 60.68% to -$907000.0 in 2025, then jumped by 98.9% to -$10000.0 in 2026.
- The last three Deferred Taxes figures came in at -$10000.0 (Q1 2026), -$907000.0 (Q4 2025), and $116000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | -1.00 Mn |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | -258.00 Mn |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | - |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | 13.89 Mn |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | 32.00 Mn |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | - |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | -38.00 Mn |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | 3.00 Mn |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | -1.99 Mn |
| 10 | Castle Biosciences | 629.76 Mn | 368.04 Mn | 63.15 Mn | -10,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -10,000.00 |
| Dec 31, 2025 | -907,000.00 |
| Sep 30, 2025 | 116,000.00 |
| Jun 30, 2025 | -4.67 Mn |
| Mar 31, 2025 | -770,000.00 |
| Dec 31, 2024 | -2.31 Mn |
| Sep 30, 2024 | 5.25 Mn |
| Jun 30, 2024 | -1.54 Mn |
| Dec 31, 2023 | -236,000.00 |
| Mar 31, 2023 | 13,000.00 |
| Dec 31, 2022 | -38,000.00 |
| Jun 30, 2022 | -1.96 Mn |
| Mar 31, 2022 | 123,000.00 |
| Dec 31, 2021 | -8.74 Mn |